NCT04493073 is a EARLY_PHASE1 clinical trial of Trabectulectomy in OCTA, sponsored by Asmaa Ahmed Ali Youssif.

Who is sponsoring NCT04493073?

NCT04493073 is sponsored by Asmaa Ahmed Ali Youssif.

What drugs are being tested in NCT04493073?

Interventions in NCT04493073: Trabectulectomy, Mitomycin, Ologen Collagen Implant, Mitomycin-C Kyowa®.

Is NCT04493073 still recruiting?

NCT04493073 is currently status unknown. Last updated 30 July 2020.

Last reviewed 2020-07-30 · How we verify

NCT04493073

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy

Status unknown EARLY_PHASE1 Last updated 30 July 2020

What this trial tests

EARLY_PHASE1 trial testing Trabectulectomy in OCTA in 100 participants. Status unknown.

Timeline

1 December 2020

Primary endpoint
1 December 2021

1 March 2022

Quick facts

Lead sponsor	Asmaa Ahmed Ali Youssif
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	triple
Primary purpose	diagnostic
Enrollment	100
Start date	1 December 2020
Primary completion	1 December 2021
Estimated completion	1 March 2022

Drugs / interventions tested

Trabectulectomy
Mitomycin (MITOMYCIN) — full drug profile →
Ologen Collagen Implant
Mitomycin-C Kyowa®

Conditions studied

OCTA — all drugs for OCTA →

Sponsor

Asmaa Ahmed Ali Youssif

Who can join

Adults 18 to 85, any sex, with OCTA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Reduce the trauma and the time taken for patient rehabilitation. * The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and trabeculectomy with ologen implants in a trial to decrease bleb failure as a common post- trabeculectomy complication. * Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb vascularity changes in glaucoma patients before and after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for OCTA

Currently open trials in the same condition.

NCT06797752 — Effect of the Stellate Ganglion Block on the Retinal Microcirculation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04493073 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asmaa Ahmed Ali Youssif
Last refreshed: 30 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04493073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing